ExploreWatchlistsPricing
  1. JP-listed companies
  2. LTT Bio-Pharma Co., Ltd.
  3. Financials
  4. Cash from operations

LTT Bio-Pharma Co., Ltd. (E00982)

Market cap
P/E ratio
LTT Biopharma develops new drugs using drug delivery and repositioning technologies, while helping Japanese and Chinese healthcare companies collaborate.
SummaryFinancialsDividendsHistoryWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Mar 31, 2025-95-126.65%
Mar 31, 2024356+453.99%
Mar 31, 202364-127.22%
Mar 31, 2022-236-206.31%
Mar 31, 2021222+292.53%
Mar 31, 202057-80.10%
Mar 31, 2019284-49.00%
Mar 31, 2018557-65.51%
Mar 31, 20171,616+5.90%
Mar 31, 20161,526+1213.15%
Mar 31, 2015116

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat